MiNK Therapeutics, Inc. (INKT) stock
INKTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$9.35+0.01 (+0.11%)
Close on Nov 16, 2026Market cap $47.71MP/E –Yield –
MiNK Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
MiNK Therapeutics's enterprise value was $43.30M on Nov 11, 2026, against $33.46M a year earlier. Over the last 5 years it ranged from $2.46M to $107.02M, with a median of $36.43M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $43.30M | +20.0% |
| 2025 | Dec 31, 2025 | $36.07M | +89.0% |
| 2024 | Dec 31, 2024 | $19.09M | -36.7% |
| 2023 | Dec 29, 2023 | $30.16M | -51.5% |
| 2022 | Dec 30, 2022 | $62.25M | -41.8% |
| 2021 | Dec 31, 2021 | $107.02M | – |
See a number that looks wrong?